Published in Transplantation on July 01, 1967
The morphology of immune reactions in normal, thymectomized and reconstituted mice. II. The response to oxazolone. Immunology (1969) 2.69
The role of afferent lymphatics in the rejection of skin homografts. J Exp Med (1968) 2.60
The morphology of immune reactions in normal, thymectomized and reconstituted mice. I. The response to sheep erythrocytes. Immunology (1969) 2.49
Studies on the sensitization of animals with simple chemical compounds. XII. The influence of excision of allergenic depots on onset of delayed hypersensitivity and tolerance. J Exp Med (1969) 2.28
Studies on the sensitization of animals with simple chemical compounds. XI. The fate of labeled picryl chloride and dinitrochlorobenzene after sensitizing injections. J Exp Med (1969) 1.62
The nature and kinetics of a delayed immune response to purified protein derivative of tuberculin in the skin of lepromatous leprosy patients. J Exp Med (1988) 1.07
DNP conjugates in guinea-pig lymph nodes during contact sensitization. Immunology (1970) 0.94
Studies on the afferent and efferent lymph of lymph nodes draining the site of application of fluorodinitrobenzene (FDNB). Immunology (1971) 0.84
[Effect of dimethyl sulfoxide on the experimentally induced contact eczema. Shortening of the minimum contact time]. Arch Dermatol Forsch (1973) 0.75
Immunological phenomena in leprosy and related diseases. Adv Immunol (1971) 5.55
Selective depletion of lymphoid tissue by cyclophosphamide. Clin Exp Immunol (1972) 5.29
Functional aspects of the selective depletion of lymphoid tissue by cyclophosphamide. Immunology (1972) 5.18
Reduced lymphocyte transformation due to a plasma factor in patients with active syphilis. Lancet (1969) 4.92
Central and peripheral effects of anti-lymphocyte sera. Lancet (1967) 3.76
Erythema nodosum leprosum: a clinical manifestation of the arthus phenomenon. Lancet (1969) 3.67
Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity. Nature (1974) 3.38
B-cell suppression of delayed hypersensitivity reactions. Nature (1974) 3.37
Further studies on B-lymphocyte suppression in delayed hypersensitivity, indicating a possible mechanism for Jones-Mote hypersensitivity. Immunology (1973) 2.65
The biological activities of soluble lymphocyte products. Clin Exp Immunol (1972) 2.58
Studies on the origin and reactive ability in vivo of peritoneal exudate cells in delayed hypersensitivity. Int Arch Allergy Appl Immunol (1967) 2.51
Suppressor cells in normal immunisation as a basic homeostatic phenomenon. Nature (1974) 2.23
Cell-mediated immunity in patients with leprosy. Lancet (1969) 2.21
Allertic complications of meningococcal disease. I. Clinical aspects. Br Med J (1973) 2.20
Complement in acute inflammation. J Pathol (1969) 2.20
Detection of mycobacterial rRNA in sarcoidosis with liquid-phase hybridisation. Lancet (1992) 2.11
A study of the passive cellular transfer of local cutaneous hypersensitivity. I. Passive transfer of delayed hypersensitivity in inbred and outbred guinea-pigs. Int Arch Allergy Appl Immunol (1965) 2.09
An analysis of the effects of some types of anti-lymphocyte sera on contact hypersensitivity and certain models of inflammation. Immunology (1968) 2.07
New antibody in early syphilis. Lancet (1970) 1.97
Cytology of the induction of hypersensitivity. Br Med Bull (1967) 1.95
Evidence for circulating immune complexes in lepromatous leprosy. Lancet (1972) 1.94
Interaction between "sensitized lymphocytes" and antigen in vitro. II. Mitogen-induced release of skin reactive and macrophage migration inhibitory factors. Cell Immunol (1970) 1.93
Immunological basis for depression of cellular immunity and the delayed allergic response in patients with lepromatous leprosy. Lancet (1968) 1.88
Electrophoretic mobility of guinea pig peritoneal exudate cells in hypersensitivity reactions. Int Arch Allergy Appl Immunol (1968) 1.88
Interaction between 'sensitized lymphocytes' and antigen in vitro. I. The release of a skin reactive factor. Immunology (1969) 1.82
Immunological significance of changes in lymph nodes across the leprosy spectrum. Clin Exp Immunol (1971) 1.76
Effect of lymphocyte mediators on macrophages in vitro. A correlation of morphological and cytochemical changes. Clin Exp Immunol (1973) 1.73
Studies on the ability of the subcellular fractions of epidermis, painted in vivo with DNFB, to cause contact sensitization in the guinea pig. Int Arch Allergy Appl Immunol (1970) 1.66
The effect of prolonged treatment with antilymphocyte serum on the course of infections with BCG and Leishmania enriettii in the guinea-pig. J Pathol (1971) 1.66
Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins. Eur J Immunol (1994) 1.61
Granuloma formation in lymph-nodes. J Pathol (1970) 1.54
Bleeding and cupping. Ann R Coll Surg Engl (1983) 1.53
Cell-mediated immunity and lymphocyte transformation in syphilis. Proc R Soc Med (1971) 1.48
Control mechanisms in delayed-type hypersensitivity. Br Med Bull (1976) 1.48
Reversal by cyclophosphamide of tolerance in contact sensitization. Tolerance induced by prior feeding with DNCB. Immunology (1975) 1.46
Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Immunology (1991) 1.44
Surface markers on lymphocytes and cells of the mononuclear phagocyte series in skin sections in leprosy. J Pathol (1978) 1.42
Effect of cyclophosphamide on immunological control mechanisms. Immunol Rev (1982) 1.40
Preliminary results on the purification of the chemical sensitizing agents in alcyonidium gelatinosum. Proc R Soc Med (1966) 1.39
Denatured muscle grafts for nerve repair. An experimental model of nerve damage in leprosy. J Bone Joint Surg Br (1990) 1.39
Metchnikoff revisited. J R Soc Med (1991) 1.36
Ultrastructure of cells present in lymph nodes during the development of contact sensitivity. Int Arch Allergy Appl Immunol (1966) 1.34
Mechanisms of reactions in leprosy. Int J Lepr Other Mycobact Dis (1972) 1.33
Immunological significance of lysosomes with lymphocytes in vivo. Nature (1965) 1.32
Cell-mediated immunological processes in leprosy. Bull World Health Organ (1969) 1.31
Release of skin reactive factor from guinea-pig lymphocytes by mitogens. Nature (1970) 1.30
Basophilic leukocytes in delayed hypersensitivity reactions. J Immunol (1974) 1.29
Epicutaneous induction of hyporeactivity in contact sensitization. Demonstration of suppressor cells induced by contact with 2,4-dinitrothiocyanatebenzene. Immunology (1975) 1.25
Comparison of mycobacterial granulomas in guinea-pig lymph nodes. J Pathol (1982) 1.25
An experimental model for the investigation of the cellular basis of desensitization in contact sensitivity. Int Arch Allergy Appl Immunol (1965) 1.24
The relation of immune depression and B-cell stimulation during the development of delayed hypersensitivity to soluble antigens. Immunology (1977) 1.23
The immunological significance of histological changes in the spleen and liver in mouse malaria. Clin Exp Immunol (1973) 1.23
Studies on contact hypersensitivity to chromium compounds. Prog Allergy (1973) 1.21
AIDS and leprosy. Lepr Rev (1988) 1.21
The genetic control of contact sensitization to inorganic metal compounds in guinea-pigs. Immunology (1968) 1.20
Dissociation between delayed-type hypersensitivity and resistance to pathogenic mycobacteria demonstrated by T-cell clones. Infect Immun (1987) 1.20
Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J Neuroimmunol (1990) 1.18
Studies on the effect of systemic administration of sensitizers in guinea-pigs with contact sensitivity to inorganic metal compounds. II. The flare-up of previous test sites of contact sensitivity and the development of a generalized rash. Clin Exp Immunol (1968) 1.17
Effects of cyclophosphamide on lymphoid tissues labelled with 5-iodo-2-deoxyuridine- 125 I and 51 Cr. Int Arch Allergy Appl Immunol (1972) 1.16
Mechanisms involved in the expression of Jones-Mote hypersensitivity. I. Passive cell transfer studies. Cell Immunol (1975) 1.16
Delayed pressure urticaria. Br J Dermatol (1968) 1.16
Release of soluble factors from lymph nodes containing mycobacterial granulomas and their effect on fibroblast function in vitro. Cell Immunol (1981) 1.15
Activation of the alternative pathway of complement by mycobacteria and cord factor. Infect Immun (1980) 1.14
H-2 linkage control of resistance to subcutaneous infection with Mycobacterium lepraemurium. Infect Immun (1982) 1.14
Studies on the effect of soluble lymphocyte products (lymphokines) on macrophage physiology. II. Cytochemical changes associated with activation. Cell Immunol (1975) 1.14
A sensitive technique for measuring specific macrophage aggregation: a comparison with macrophage migration inhibition, for the detection of lymphokine activity. Immunology (1979) 1.12
The value of an assessment of erythema and increase in thickness of the skin reaction for a full appreciation of the nature of delayed hypersensitivity in the guinea pig. Int Arch Allergy Appl Immunol (1977) 1.11
Modification of cutaneous leishmaniasis in the guinea-pig by cyclophosphamide. Clin Exp Immunol (1976) 1.11
Nephrotic syndrome due to ammoniated mercury. Br J Dermatol (1968) 1.10
Dissociation between lymph node and peripheral reactivity in immunological unresponsiveness to DNCB. Immunology (1973) 1.10
Suppression of delayed hypersensitivity to tuberculin by antigenic competition. A positive immunoregulatory mechanism sensitive to cyclophosphamide. Immunology (1981) 1.09
Changes in macrophages in vivo induced by desensitization. Cell Immunol (1976) 1.08
A lack of correlation between antigen-specific cellular reactions and resistance to Mycobacterium lepraemurium infection in mice. Immunology (1981) 1.08
Mitsuda-type lepromin reactions as a measure of host resistance in Mycobacterium lepraemurium infection. Infect Immun (1979) 1.08
Cytokines in the central nervous system of mice during chronic relapsing experimental allergic encephalomyelitis. Cell Immunol (1991) 1.08
Denatured autologous muscle graft in leprosy. Lancet (1991) 1.08
Chronic malarial infection in Balb/C mice. Effect on the immune response to sheep erythrocytes and histological changes in the liver and spleen. Trans R Soc Trop Med Hyg (1975) 1.07
An analysis of the multiplicity of the effects of antilymphocyte serum. A comparison with the action of other immunosuppressive agents in the cell-mediated immune response and non-specific inflammation. Antibiot Chemother (1969) 1.06
Granuloma formation in normal guinea pigs injected intradermally with aluminum and zirconium compounds. J Invest Dermatol (1977) 1.05
Studies on the ability of the soluble proteins from skin, painted in vivo with DNFB, to cause contact sensitivity in the guinea pig. Int Arch Allergy Appl Immunol (1970) 1.05
Studies on the effect of systemic administration of sensitizers in guinea-pigs with contact sensitivity to inorganic metal compounds. I. The induction of immunological unresponsiveness in already sensitized animals. Clin Exp Immunol (1968) 1.04
Isolation and characterization of cells infiltrating the spinal cord during the course of chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse. Cell Immunol (1993) 1.04
The origin, morphology, and function of epithelioid cells. Immunobiology (1982) 1.04
The relation between B-cell stimulation and delayed hypersensitivity. The effect of cyclophosphamide pretreatment on antibody production. Immunology (1977) 1.03
Ultrastructural observations on epithelioid cell granulomas induced by zirconium in the guinea-pig. J Pathol (1978) 1.03
Central and peripheral action of suppressor cells in contact sensitivity in the guinea-pig. Immunology (1976) 1.03
Suppression of the haemorrhagic component of the Schwartzmann reaction by anti-complement serum. Nature (1969) 1.02
Sensitization with Cr, Ni and Zr salts and allergic type granuloma formation in the guinea pig. J Invest Dermatol (1977) 1.01
Genetic analysis of experimental allergic encephalomyelitis in mice. J Immunol (1995) 1.01
Differential expression of guinea pig class II major histocompatibility complex antigens on vascular endothelial cells in vitro and in experimental allergic encephalomyelitis. Cell Immunol (1989) 0.99
A histochemical analysis of mononuclear cell infiltrates of the skin. II. Delayed hypersensitivity in the human. Int Arch Allergy Appl Immunol (1966) 0.98
The role of macrophages in skin allograft rejection. I. Histochemical studies during first-set rejection. Transplantation (1971) 0.98
Macrophage specific antigen is expressed by resting microglia in the CNS but not by Langerhans cells in the skin. J Pathol (1983) 0.97
Regulation of lymphocyte proliferation in contact sensitivity: homeostatic mechanisms and a possible explanation of antigenic competition. Immunology (1989) 0.97
A study of the passive cellular transfer of local cutaneous hypersensitivity. II. The possible role of cytophilic antibody in cutaneous hypersensitivity reactions. Int Arch Allergy Appl Immunol (1965) 0.97
H-2-linked genes which modify resistance of C57BL/10 mice to subcutaneous infection with Mycobacterium lepraemurium. Infect Immun (1984) 0.97
Endothelial cell expression of the intercellular adhesion molecule-1 (ICAM-1) in the central nervous system of guinea pigs during acute and chronic relapsing experimental allergic encephalomyelitis. J Neuroimmunol (1990) 0.97
Granuloma formation in lymph nodes. Proc R Soc Med (1971) 0.96
The monocyte-macrophage system in granulomatous inflammation. Haematol Blood Transfus (1981) 0.96